DNMT3A通过调节ADAMTS8介导的EGFR-MEK-ERK激活来促进乳腺癌的进展
Shan Yang1,2, Meng Cheng1, Shaonan Zhang1
1Department of Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
PloS one
|May 5, 2025
概括
DNA甲基转移酶3A (DNMT3A) 通过表观遗传沉默ADAMTS8.8促进乳腺癌的进展. 这种机制激活了EGFR-MEK-ERK通路,突出显示DNMT3A是乳腺癌的潜在治疗标.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 通过表观遗传修饰的ADAMTS8失活与各种癌症和不良的临床结果有关.
- 通过DNMT3A进行De novo甲基化对于癌症的发展至关重要,但其在通过ADAMTS8调节促进乳腺癌进展中的作用尚不清楚.
研究的目的:
- 研究DNMT3A在调节ADAMTS8表达中的作用及其对乳腺癌进展的影响.
- 阐明DNMT3A影响乳腺癌发展的分子机制.
主要方法:
- 对癌症相关数据集的分析和临床验证.
- 细胞实验 (过度表达和沉默).
- 同免疫沉 (Co-IP) 和甲基化特定PCR (MSP).
主要成果:
- 在乳腺癌中,ADAMTS8和DNMT3A的表达具有负相关性,并且与患者的预后有关.
- DNMT3A的过度表达促进了乳腺癌细胞的增殖,迁移,入侵,并抑制了亡.
- DNMT3A直接与ADAMTS8结合,调解其促进物甲基化,并沉默其转录,激活EGFR-MEK-ERK通路.
结论:
- 通过甲基化,DNMT3A通过沉默ADAMTS8转录促进乳腺癌的发展,从而激活EGFR-MEK-ERK信号通路.
- DNMT3A代表了乳腺癌向治疗的潜在抑制标.
更多相关视频
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
12.6K
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
2.5K
相关概念视频
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
Abnormal Proliferation
4.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K
Enzyme-linked Receptors
75.9K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
75.9K
MAPK Signaling Cascades
4.9K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
4.9K
